We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$583M
AUM Growth
+$61.1M
Cap. Flow
+$9.77M
Cap. Flow %
1.68%
Top 10 Hldgs %
74.2%
Holding
69
New
2
Increased
7
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$7.58M
2
CI icon
Cigna
CI
+$1.5M
3
ABBV icon
AbbVie
ABBV
+$785K
4
KMI icon
Kinder Morgan
KMI
+$558K
5
FFIV icon
F5
FFIV
+$483K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$847K
2
BMY icon
Bristol-Myers Squibb
BMY
+$453K
3
AAPL icon
Apple
AAPL
+$170K
4
JNJ icon
Johnson & Johnson
JNJ
+$161K
5
JPM icon
JPMorgan Chase
JPM
+$34K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40%
2 Healthcare 38.26%
3 Energy 5.43%
4 Communication Services 4.67%
5 Technology 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$29.5B
$228M 39.11%
8,107,252
+8,200
+0.1% +$226K
ZTS icon
2
Zoetis
ZTS
$31.1B
$33.8M 5.8%
335,766
– –
ABT icon
3
Abbott
ABT
$190B
$27.9M 4.78%
348,430
– –
DIS icon
4
Walt Disney
DIS
$179B
$25.1M 4.31%
226,200
– –
JNJ icon
5
Johnson & Johnson
JNJ
$626B
$23.4M 4.01%
167,076
-1,200
-0.7% -$161K
MRK icon
6
Merck
MRK
$322B
$20.4M 3.49%
256,708
+734
+0.3% +$54.9K
BMY icon
7
Bristol-Myers Squibb
BMY
$130B
$20.3M 3.49%
426,145
-9,100
-2% -$453K
LLY icon
8
Eli Lilly
LLY
$1.08T
$20.3M 3.47%
156,057
-6,963
-4% -$847K
PFE icon
9
Pfizer
PFE
$152B
$18.5M 3.17%
458,412
– –
ABBV icon
10
AbbVie
ABBV
$442B
$15.1M 2.58%
186,770
+9,600
+5% +$785K
AAPL icon
11
Apple
AAPL
$4.45T
$13.4M 2.29%
281,828
-4,000
-1% -$170K
ZBH icon
12
Zimmer Biomet
ZBH
$18.5B
$13.1M 2.25%
105,627
– –
KMB icon
13
Kimberly-Clark
KMB
$36.1B
$12.8M 2.19%
103,300
– –
BAX icon
14
Baxter International
BAX
$14.3B
$11.3M 1.93%
138,550
– –
KMI icon
15
Kinder Morgan
KMI
$70.1B
$9.64M 1.65%
481,849
+29,885
+7% +$558K
MSFT icon
16
Microsoft
MSFT
$3.74T
$8.43M 1.45%
71,500
– –
CAT icon
17
Caterpillar
CAT
$388B
$8.13M 1.39%
60,005
– –
ELAN icon
18
Elanco Animal Health
ELAN
$11.4B
$7.9M 1.36%
+246,414
New +$7.58M
CI icon
19
Cigna
CI
$72.4B
$5.03M 0.86%
31,287
+8,210
+36% +$1.5M
PG icon
20
Procter & Gamble
PG
$338B
$4.75M 0.81%
45,671
– –
MA icon
21
Mastercard
MA
$492B
$4.71M 0.81%
20,000
– –
EPD icon
22
Enterprise Products Partners
EPD
$81.8B
$4.58M 0.79%
157,570
– –
BRK.B icon
23
Berkshire Hathaway Class B
BRK.B
$1.11T
$4.11M 0.71%
20,470
– –
MMP
24
DELISTED
Magellan Midstream Partners, L.P.
MMP
$3.93M 0.67%
64,800
– –
TCP
25
DELISTED
TC Pipelines LP
TCP
$3.56M 0.61%
95,400
– –
1
2 3

Similar funds

FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Blackhill Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Blackhill Capital held 69 positions worth $583M, up 12% from $522M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4.3%. Blackhill Capital opened 2 new positions and exited 1, leaving the 69-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Healthcare and Energy.

  • Blackhill Capital's largest Q1 2019 buy was Elanco Animal Health: 246,414 shares worth $7.9M.
  • Blackhill Capital added most to Cigna in Q1 2019, an estimated $1.5M increase.
  • Blackhill Capital's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $847K.
  • Blackhill Capital fully exited JPMorgan Chase in Q1 2019, selling an estimated $34K.
  • Blackhill Capital's ten largest holdings make up 74% of its $583M portfolio in Q1 2019.
  • Blackhill Capital opened 2 new positions and closed 1 in Q1 2019.
  • Blackhill Capital's portfolio value rose 12% quarter-over-quarter to $583M.

Based on Blackhill Capital's 13F filing for Q1 2019, filed 2 May 2019.